Safapac Holdings Limited

Safapac Holdings Limited is a UK-based company specializing in contract manufacturing, packaging, and storage of liquid chemical products, including hazardous materials, serving a diverse clientele across various sectors. Founded in 1996, Safapac Holdings Limited operates as a contract manufacturer and packager of liquid chemicals. The company has maintained a consistent focus on servicing industries such as agricultural and veterinary products. Headquartered in Peterborough, UK, it has expanded its operations to cater to both domestic and international markets.

The founder's history is not publicly detailed, and there are no mentions of the company undergoing significant pivots or having parent companies or subsidiaries. Recent funding details are not specified. Safapac specializes in contract manufacturing, packing, and storage of liquid chemical products, including those classified as hazardous and flammable. The company offers services ranging from liquid blending and bead milling to filtration and nitrogen purging, catering to a variety of client needs.

Safapac also provides advanced packaging solutions, including labeling and batch coding with two-dimensional barcodes for serialization. Its purpose-built facility in Peterborough serves clients in sectors like farm chemicals, veterinary and pet care, and medical and hygiene products, supporting both UK and international markets. Safapac's revenue model is based on B2B contracts for manufacturing and packaging services across various industries, particularly agriculture and veterinary sectors. Contracts are project-based, often requiring upfront deposits with final payments due upon delivery.

The company's services include producing veterinary medicines, which adhere to stringent regulatory standards, positioning Safapac as a reliable partner in high-compliance markets. Specific pricing structures are not disclosed, but the company emphasizes quality and traceability. Information regarding upcoming products or specific market expansion plans has not been disclosed. Detailed insights into the utilization of recent funding are also unavailable, making it difficult to outline future strategies.